The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
Roles of PFKFB3 in cancer
Open accessAbstract
The understanding of 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFK-2/FBPase 3, PFKFB3) has advanced considerably since its initial identification in human macrophages in the mid-1990s. As a vital regulator of glycolysis, accumulating studies have suggested that PFKFB3 is associated with many aspects of cancer, including carcinogenesis, cancer cell proliferation, vessel aggressiveness, drug resistance and tumor microenvironment. In this review, we summarize current knowledge of PFKFB3 regulation by several signal pathways and its function in cancer development in different cell types in cancer tissues. Ubiquitous PFKFB3 has emerged as a potential target for anti-neoplastic therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Inflammatory Bowel Disease as a Risk Factor for Colorectal Cancer
Lukas, M. (2010) · Digestive Diseases · doi:10.1159/000320276 · Cited by 88
RetractedCoussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Shaw, G., & Kamen, R. (1986) · Cell · doi:10.1016/0092-8674(86)90341-7 · Cited by 4,012
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Basic and Therapeutic Aspects of Angiogenesis
Potente, M., Gerhardt, H., & Carmeliet, P. (2011) · Cell · doi:10.1016/j.cell.2011.08.039 · Cited by 2,771
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chang, C.-H., Curtis, J. D., Maggi, L. B., Faubert, B., Villarino, A. V., O’Sullivan, D., Huang, S. C.-C., van der Windt, G. J. W., Blagih, J., Qiu, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.016 · Cited by 2,204
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
AU-rich elements: characterization and importance in mRNA degradation
Chen, C.-Y. A., & Shyu, A.-B. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89102-1 · Cited by 1,948
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628
Interferons, immunity and cancer immunoediting
Dunn, G. P., Koebel, C. M., & Schreiber, R. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1961 · Cited by 1,617
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Jain, R. K. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.006 · Cited by 1,589
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
De Bock, K., Georgiadou, M., Schoors, S., Kuchnio, A., Wong, B. W., Cantelmo, A. R., Quaegebeur, A., Ghesquière, B., Cauwenberghs, S., Eelen, G., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.037 · Cited by 1,551
Creighton, C. J., Li, X., Landis, M., Dixon, J. M., Neumeister, V. M., Sjolund, A., Rimm, D. L., Wong, H., Rodriguez, A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,412
Lagadinou, E. D., Sach, A., Callahan, K., Rossi, R. M., Neering, S. J., Minhajuddin, M., Ashton, J. M., Pei, S., Grose, V., O’Dwyer, K. M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.013 · Cited by 1,399
Cancer stem cells: an old idea–a paradigm shift
Wicha, M. S., Liu, S., & Dontu, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3153 · Cited by 1,378
Fueling Immunity: Insights into Metabolism and Lymphocyte Function
Pearce, E. L., Poffenberger, M. C., Chang, C.-H., & Jones, R. G. (2013) · Science · doi:10.1126/science.1242454 · Cited by 1,363
Molecular Definition of Breast Tumor Heterogeneity
Shipitsin, M., Campbell, L. L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.01.013 · Cited by 1,353
Santos, C. R., & Schulze, A. (2012) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08644.x · Cited by 1,335
Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function
Viale, A., Pettazzoni, P., Lyssiotis, C. A., Ying, H., Sánchez, N., Marchesini, M., Carugo, A., Green, T., Seth, S., Giuliani, V., et al. (2014) · Nature · doi:10.1038/nature13611 · Cited by 1,259
Toll-like receptor–induced changes in glycolytic metabolism regulate dendritic cell activation
Krawczyk, C. M., Holowka, T., Sun, J., Blagih, J., Amiel, E., DeBerardinis, R. J., Cross, J. R., Jung, E., Thompson, C. B., Jones, R. G., et al. (2010) · Blood · doi:10.1182/blood-2009-10-249540 · Cited by 1,246
Everts, B., Amiel, E., Huang, S. C.-C., Smith, A. M., Chang, C.-H., Lam, W. Y., Redmann, V., Freitas, T. C., Blagih, J., van der Windt, G. J. W., et al. (2014) · Nature Immunology · doi:10.1038/ni.2833 · Cited by 1,064
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 911
Herrero-Mendez, A., Almeida, A., Fernández, E., Maestre, C., Moncada, S., & Bolaños, J. P. (2009) · Nature Cell Biology · doi:10.1038/ncb1881 · Cited by 844
Loss of FBP1 by Snail-Mediated Repression Provides Metabolic Advantages in Basal-like Breast Cancer
Dong, C., Yuan, T., Wu, Y., Wang, Y., Fan, T. W. M., Miriyala, S., Lin, Y., Yao, J., Shi, J., Kang, T., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.01.022 · Cited by 804
Foretz, M., Guichard, C., Ferré, P., & Foufelle, F. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12737 · Cited by 747
Cantelmo, A. R., Conradi, L.-C., Brajic, A., Goveia, J., Kalucka, J., Pircher, A., Chaturvedi, P., Hol, J., Thienpont, B., Teuwen, L.-A., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.006 · Cited by 659
Weber, G. (1977) · New England Journal of Medicine · doi:10.1056/nejm197703032960905 · Cited by 641
Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells
Janiszewska, M., Suvà, M. L., Riggi, N., Houtkooper, R. H., Auwerx, J., Clément-Schatlo, V., Radovanovic, I., Rheinbay, E., Provero, P., & Stamenkovic, I. (2012) · Genes & Development · doi:10.1101/gad.188292.112 · Cited by 452
Family history as a risk factor for colorectal cancer in inflammatory bowel disease
Askling, J., Dickman, P. W., Ekbom, A., Karlén, P., Broström, O., Lapidus, A., & Löfberg, R. (2001) · Gastroenterology · doi:10.1053/gast.2001.24052 · Cited by 450
RIDER, M. H., BERTRAND, L., VERTOMMEN, D., MICHELS, P. A., ROUSSEAU, G. G., & HUE, L. (2004) · Biochemical Journal · doi:10.1042/bj20040752 · Cited by 440
Clem, B., Telang, S., Clem, A., Yalcin, A., Meier, J., Simmons, A., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 432
Marsin, A.-S., Bouzin, C., Bertrand, L., & Hue, L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205213200 · Cited by 379
Coordinating cell behaviour during blood vessel formation
Geudens, I., & Gerhardt, H. (2011) · Development · doi:10.1242/dev.062323 · Cited by 376
Liao, J., Qian, F., Tchabo, N., Mhawech-Fauceglia, P., Beck, A., Qian, Z., Wang, X., Huss, W. J., Lele, S. B., Morrison, C. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084941 · Cited by 364
Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B. (2005) · Oncogene · doi:10.1038/sj.onc.1208622 · Cited by 357
PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate
Okar, D. A., Lange, A. J., Manzano, À., Navarro-Sabatè, A., Riera, L., & Bartrons, R. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)01699-6 · Cited by 357
Revving the Engine: Signal Transduction Fuels T Cell Activation
Jones, R. G., & Thompson, C. B. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.008 · Cited by 349
Atsumi, T., Chesney, J. A., Metz, C. N., Leng, L., Donnelly, S. C., Makita, Z., Mitchell, R., & Bucala, R. (2002) · PubMed · Cited by 323
The fat side of prostate cancer
Zadra, G., Photopoulos, C., & Loda, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.03.010 · Cited by 291
Chesney, J., Mitchell, R., Benigni, F., Bacher, M., Spiegel, L., Al-Abed, Y., Han, J. H., Metz, C., & Bucala, R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3047 · Cited by 287
6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE: A METABOLIC SIGNALING ENZYME
Pilkis, S. J., Claus, T. H., Kurland, I. J., & Lange, A. J. (1995) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.64.070195.004055 · Cited by 283
Targeting 6-Phosphofructo-2-Kinase (PFKFB3) as a Therapeutic Strategy against Cancer
Clem, B. F., O'Neal, J., Tapolsky, G., Clem, A. L., Imbert-Fernandez, Y., Kerr, D. A., Klarer, A. C., Redman, R., Miller, D. M., Trent, J. O., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0097 · Cited by 276
AMPK and PFKFB3 mediate glycolysis and survival in response to mitophagy during mitotic arrest
Doménech, E., Maestre, C., Esteban-Martínez, L., Partida, D., Pascual, R., Fernández-Miranda, G., Seco, E., Campos-Olivas, R., Pérez, M., Megias, D., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3231 · Cited by 272
Glucose Regulation of Gene Transcription
Vaulont, S., Vasseur-Cognet, M., & Kahn, A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000016200 · Cited by 267
Aerobically Derived Lactate Stimulates Revascularization and Tissue Repair via Redox Mechanisms
Hunt, T. K., Aslam, R. S., Beckert, S., Wagner, S., Ghani, Q. P., Hussain, M. Z., Roy, S., & Sen, C. K. (2007) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1674 · Cited by 261
Reduced methylation of PFKFB3 in cancer cells shunts glucose towards the pentose phosphate pathway
Yamamoto, T., Takano, N., Ishiwata, K., Ohmura, M., Nagahata, Y., Matsuura, T., Kamata, A., Sakamoto, K., Nakanishi, T., Kubo, A., et al. (2014) · Nature Communications · doi:10.1038/ncomms4480 · Cited by 250
Metabolic Alterations in Highly Tumorigenic Glioblastoma Cells
Zhou, Y., Zhou, Y., Shingu, T., Feng, L., Chen, Z., Ogasawara, M., Keating, M. J., Kondo, S., & Huang, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.260935 · Cited by 250
Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors.
Van Schaftingen, E., Jett, M. F., Hue, L., & Hers, H. G. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3483 · Cited by 246
Yalcin, A., Clem, B. F., Simmons, A., Lane, A., Nelson, K., Clem, A. L., Brock, E., Siow, D., Wattenberg, B., Telang, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.016816 · Cited by 242
p27Kip1 overexpression causes apoptotic death of mammalian cells
Wang, X., Gorospe, M., Huang, Y., & Holbrook, N. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201450 · Cited by 221
Bando, H., Atsumi, T., Nishio, T., Niwa, H., Mishima, S., Shimizu, C., Yoshioka, N., Bucala, R., & Koike, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0149 · Cited by 210
Yalcin, A., Clem, B. F., Imbert-Fernandez, Y., Ozcan, S. C., Peker, S., O'Neal, J., Klarer, A. C., Clem, A. L., Telang, S., & Chesney, J. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.292 · Cited by 199
Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
Pisarsky, L., Bill, R., Fagiani, E., Dimeloe, S., Goosen, R. W., Hagmann, J., Hess, C., & Christofori, G. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.028 · Cited by 197
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes
Roos, D., & Loos, J. A. (1973) · Experimental Cell Research · doi:10.1016/0014-4827(73)90561-2 · Cited by 182
Fructose‐2,6‐bisphosphate and control of carbohydrate metabolism in eukaryotes
Okar, D. A., & Lange, A. J. (1999) · BioFactors · doi:10.1002/biof.5520100101 · Cited by 178
Blum, R., Jacob‐Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · PubMed · Cited by 178
Ras transformation requires metabolic control by 6-phosphofructo-2-kinase
Telang, S., Yalcin, A., Clem, A. L., Bucala, R., Lane, A. N., Eaton, J. W., & Chesney, J. (2006) · Oncogene · doi:10.1038/sj.onc.1209709 · Cited by 168
Regulation of rat liver fructose 2,6-bisphosphatase.
El-Maghrabi, M. R., Claus, T. H., Pilkis, J., Fox, E., & Pilkis, S. J. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34422-3 · Cited by 163
Blum, R., Jacob-Hirsch, J., Amariglio, N., Rechavi, G., & Kloog, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.999.65.3 · Cited by 161
Characterization of a Human Placental Fructose-6-Phosphate, 2-Kinase/Fructose- 2,6 - Bisphosphatase
Sakakibara, R., Kato, M., Okamura, N., Nakagawa, T., Komada, Y., Tominaga, N., Shimojo, M., & Fukasawa, M. (1997) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021719 · Cited by 152
Energy Metabolism Characterization of a Novel Cancer Stem Cell‐ L ike Line 3 AB ‐ OS
Palorini, R., Votta, G., Balestrieri, C., Monestiroli, A., Olivieri, S., Vento, R., & Chiaradonna, F. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24671 · Cited by 149
Hypersensitization of Tumor Cells to Glycolytic Inhibitors
Liu, H., Hu, Y., Savaraj, N., Priebe, W., & Lampidis, T. J. (2001) · Biochemistry · doi:10.1021/bi002426w · Cited by 148
Signaling Takes a Breath – New Quantitative Perspectives on Bioenergetics and Signal Transduction
Krauss, S., Brand, M. D., & Buttgereit, F. (2001) · Immunity · doi:10.1016/s1074-7613(01)00205-9 · Cited by 147
Wang, H., Xie, H., Wang, J., Wu, J., Ma, X., Li, L., Wei, X., Ling, Q., Song, P., Zhou, L., et al. (2015) · Advanced Functional Materials · doi:10.1002/adfm.201501953 · Cited by 141
Li, H., Yang, J., Liu, Z., Wang, W., Yu, Z., Ren, J., Chen, G., Zhang, W., & Jia, J. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-016-0481-1 · Cited by 139
Self-citationTudzarova, S., Colombo, S. L., Stoeber, K., Carcamo, S., Williams, G. H., & Moncada, S. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102247108 · Cited by 136
Central role of lactic acidosis in cancer cell resistance to glucose deprivation‐induced cell death
Wu, H., Ding, Z., Hu, D., Sun, F., Dai, C., Xie, J., & Hu, X. (2011) · The Journal of Pathology · doi:10.1002/path.3978 · Cited by 132
Self-citationInhibition of Glycolytic Enzymes Mediated by Pharmacologically Activated p53
Zawacka‐Pankau, J., Grinkevich, V. V., Hünten, S., Nikulenkov, F., Gluch, A., Li, H., Enge, M., Kel, A. E., & Selivanova, G. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.240812 · Cited by 130
Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting
Vandekeere, S., Dewerchin, M. A., & Carmeliet, P. (2015) · Microcirculation · doi:10.1111/micc.12229 · Cited by 126
Zhu, W. J., Liang, Y. S., Zhang, J., Yu, P., Wang, H., Ye, Z., & Tian, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163768 · Cited by 125
Calvo, M., Bartrons, R., Castaño, E., Perales, J. C., Navarro‐Sabaté, À., & Manzano, À. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.093 · Cited by 124
Chao, M., Wu, H., Jin, K., Li, B., Wu, J., Zhang, G., Yang, G., & Hu, X. (2016) · eLife · doi:10.7554/elife.15691 · Cited by 116
Murata, R., Nishimura, Y., & Hiraoka, M. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00628-1 · Cited by 112
O’Neal, J., Clem, A. L., Reynolds, L., Dougherty, S. M., Imbert-Fernandez, Y., Telang, S., Chesney, J. A., & Clem, B. F. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3968-8 · Cited by 112
The secretome of colon cancer stem cells contains drug-metabolizing enzymes
Emmink, B. L., Verheem, A., van Houdt, W. J., Steller, E. J. A., Govaert, K. M., Pham, T. V., Piersma, S. R., Rinkes, I. H. M. B., Jiménez, C. R., & Kranenburg, O. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.06.027 · Cited by 110
Ando, M., Uehara, I., Kogure, K., Asano, Y., Nakajima, W., Abe, Y., Kawauchi, K., & Tanaka, N. (2010) · Journal of Nippon Medical School · doi:10.1272/jnms.77.97 · Cited by 107
Metabolic properties of freshly isolated bovine endothelial cells
Dobrina, A., & Rossi, F. (1983) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(83)90084-8 · Cited by 106
Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation
Telang, S., Clem, B. F., Klarer, A. C., Clem, A. L., Trent, J. O., Bucala, R., & Chesney, J. A. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-95 · Cited by 102
Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism
Klarer, A. C., O’Neal, J., Imbert-Fernandez, Y., Clem, A. L., Ellis, S. R., Clark, J. A., Clem, B. F., Chesney, J. A., & Telang, S. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-2 · Cited by 102
Theoretical Simulation of Oxygen Transport to Tumors by Three-Dimensional Networks of Microvessels
Secomb, T. W., Hsu, R., Braun, R. D., Ross, J. R., Gross, J. F., & Dewhirst, M. W. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4863-8_74 · Cited by 97
Mechanisms of regulation of PFKFB expression in pancreatic and gastric cancer cells
Minchenko, О. H., Tsuchihara, K., Minchenko, D. O., Bikfalvi, A., & Esumi, H. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13705 · Cited by 97
Du, J., Wang, L., Wang, Q., & Yu, L. (2015) · Oncology Reports · doi:10.3892/or.2015.3797 · Cited by 96
Wang, H., Xie, H., Wu, J., Wei, X., Zhou, L., Xu, X., & Zheng, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201406685 · Cited by 96
Ruiz-García, A., Monsalve, E., Novellasdemunt, L., Navarro-Sabaté, À., Manzano, A., Rivero, S., Castrillo, A., Casado, M., Laborda, J., Bartrons, R., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190298 · Cited by 95
Dll4-Notch signaling in regulation of tumor angiogenesis
Liu, Z., Fan, F., Wang, A., Zheng, S., & Lu, Y. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1534-x · Cited by 95
Self-citationEstradiol Stimulates Glucose Metabolism via 6-Phosphofructo-2-kinase (PFKFB3)
Imbert-Fernandez, Y., Clem, B. F., O’Neal, J., Kerr, D. A., Spaulding, R. T., Lanceta, L., Clem, A. L., Telang, S., & Chesney, J. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.529990 · Cited by 95
PFKFB3 activation in cancer cells by the p38/MK2 pathway in response to stress stimuli
Novellasdemunt, L., Bultot, L., Manzano, À., Ventura, F., Rosa, J. L., Vertommen, D., Rider, M. H., Navarro‐Sabaté, À., & Bartrons, R. (2013) · Biochemical Journal · doi:10.1042/bj20121886 · Cited by 89
Ge, X., Lyu, P., Cao, Z., Li, J., Guo, G., Xia, W., & Gu, Y. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.068 · Cited by 85
Seo, M., Kim, J., Neau, D. B., Sehgal, I., & Lee, Y. H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024179 · Cited by 83
Desideri, E., Vegliante, R., Cardaci, S., Nepravishta, R., Paci, M., & Ciriolo, M. R. (2014) · Autophagy · doi:10.4161/auto.29456 · Cited by 79
PFKFB3 Regulates Oxidative Stress Homeostasis via Its S-Glutathionylation in Cancer
Seo, M., & Lee, Y. H. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.11.021 · Cited by 74
Cancer Stem Cell Theory and the Warburg Effect, Two Sides of the Same Coin?
Pacini, N., & Borziani, F. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15058893 · Cited by 72
mTOR up-regulation of PFKFB3 is essential for acute myeloid leukemia cell survival
Feng, Y., & Wu, L.-S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.031 · Cited by 70
Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer
HAN, J., Meng, Q., Xi, Q., Zhang, Y., Zhuang, Q., Han, Y., Jiang, Y., Ding, Q., & Wu, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3225 · Cited by 65
Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality
Chesney, J. A., Telang, S., Yalçın, A., Clem, A. L., Wallis, N. K., & Bucala, R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.193 · Cited by 64
Fukasawa, M. (2004) · The Journal of Biochemistry · doi:10.1093/jb/mvh137 · Cited by 64
Wang, H., Wu, J., Xie, K., Fang, T., Chen, C., Xie, H., Zhou, L., & Zheng, S. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b01938 · Cited by 61
Lu, Q., Yan, S., Sun, H., Wang, W., Li, Y., Yang, X., Jiang, X., Che, Y., & Xi, Z. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.344 · Cited by 59
Regulation of 6-phosphofructo-1-kinase activity in ras-transformed rat-1 fibroblasts
Kole, H. K., Resnick, R. J., Van Doren, M., & Racker, E. (1991) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(91)90084-v · Cited by 57
Prognostic value of microvessel density in invasive ductal carcinoma of the breast
Tsutsui, S., Kume, M., & Era, S. (2003) · Breast Cancer · doi:10.1007/bf02967651 · Cited by 54
Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain
Keßler, R., & Eschrich, K. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00014-6 · Cited by 53
Novellasdemunt, L., Obach, M., Millán-Ariño, L., Manzano, À., Ventura, F., Rosa, J. L., Jordan, A., Navarro‐Sabaté, À., & Bartrons, R. (2011) · Biochemical Journal · doi:10.1042/bj20111418 · Cited by 52
Cordero-Espinoza, L., & Hagen, T. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.510289 · Cited by 50
Insulin induces PFKFB3 gene expression in HT29 human colon adenocarcinoma cells
Riera, L., Manzano, À., Navarro‐Sabaté, À., Perales, J. C., & Bartrons, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00169-6 · Cited by 49
Cieślar‐Pobuda, A., Jain, M. V., Kratz, G., Rzeszowska‐Wolny, J., Ghavami, S., & Wiecheć, E. (2015) · Oncotarget · doi:10.18632/oncotarget.4995 · Cited by 47
Han, J., Meng, Q., Xi, Q., Wang, H., & Wu, G. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160143 · Cited by 46
Lea, M. A., Guzman, Y., & desBordes, C. (2016) · PubMed · Cited by 44
Control of Glycolytic Flux by AMP-Activated Protein Kinase in Tumor Cells Adapted to Low pH
Mendoza, E. E., Pocceschi, M. G., Kong, X., Leeper, D. B., Caro, J., Limesand, K. H., & Burd, R. (2012) · Translational Oncology · doi:10.1593/tlo.11319 · Cited by 43
Brooke, D. G., van Dam, E. M., Watts, C. K. W., Khoury, A., Dziadek, M. A., Brooks, H., Graham, L.-J. K., Flanagan, J. U., & Denny, W. A. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.041 · Cited by 41
Yalçın, A., Altunok, T. H., Özcan, S. C., Güzel, S., Peker, S., Çelikler, S., Balaban, B. D., Demirdöğen, E., Gurpinar, Y., & Chesney, J. A. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.178 · Cited by 41
Okamura, N., & Sakakibara, R. (1998) · Bioscience Biotechnology and Biochemistry · doi:10.1271/bbb.62.2039 · Cited by 38
Glu327 is part of a catalytic triad in rat liver fructose-2,6-bisphosphatase.
Lin, K. F., Li, L., Correia, J. J., & Pilkis, S. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50463-x · Cited by 37
PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs
Chen, L., Zhao, J., Tang, Q., Li, H., Zhang, C., Yu, R., Zhao, Y., Huo, Y., & Wu, C. (2016) · Scientific Reports · doi:10.1038/srep24324 · Cited by 36
Alvero, A. B., Montagna, M. K., Sumi, N. J., Joo, W. D., Graham, E., & Mor, G. (2014) · Oncotarget · doi:10.18632/oncotarget.2367 · Cited by 31
Inflammation in cancer: a therapeutic target?
Trinchieri, G. (2011) · PubMed · Cited by 30
Wang, H., Xie, H., Wu, J., Wei, X., Zhou, L., Xu, X., & Zheng, S. (2014) · Angewandte Chemie · doi:10.1002/ange.201406685 · Cited by 26
MicroRNA-26b inhibits osteosarcoma cell migration and invasion by down-regulating PFKFB3 expression
Zheng, W., Zhou, F. L., & Lin, N. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.14.14 · Cited by 24
Zscharnack, K., Keßler, R., Bleichert, F., Warnke, J. P., & Eschrich, K. (2009) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2009.01027.x · Cited by 22
LOH on 10p14‐p15 targets the PFKFB3 gene locus in human glioblastomas
Fleischer, M., Keßler, R., Klammer, A., Warnke, J., & Eschrich, K. (2011) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20914 · Cited by 20
Kumar, P., Sharoyko, V. V., Spégel, P., Gullberg, U., Mulder, H., Olsson, I., & Ajore, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068502 · Cited by 19
Targeting 6-phosphofructo-2-kinase (PFKFB3) as an immunotherapeutic strategy.
Chesney, J. A., Telang, S., Yaddanapudi, K., & Grewal, J. S. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.34.15_suppl.e14548 · Cited by 15
Telang, S., Yaddanapudi, K., Grewal, J. S., Redman, R. A., Fu, S., Pohlmann, P. R., Mahalingam, D., Kurman, M. R., Tapolsky, G. H., & Chesney, J. A. (2016) · Cancer Research · doi:10.1158/1538-7445.panca16-b90 · Cited by 8
Shaw, G. D., & Kamen, R. (2012) · The Journal of Immunology · doi:10.1093/jimmunol/189.1.5 · Cited by 8
Cited by
Metabolic reprogramming in macrophage responses
Liu, Y., Xu, R., Gu, H., Zhang, E., Qu, J., Cao, W., Huang, X., Yan, H., He, J., & Cai, Z. (2021) · Biomarker Research · doi:10.1186/s40364-020-00251-y · Cited by 641
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499
Hypoxia and Selective Autophagy in Cancer Development and Therapy
Daskalaki, I., Gkikas, I., & Tavernarakis, N. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00104 · Cited by 188
The mechanism of Warburg effect-induced chemoresistance in cancer
Liu, C., Jin, Y., & Fan, Z. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.698023 · Cited by 177
Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144
Metadata
- Authors
- Shi, L., Pan, H., Liu, Z., Xie, J., & Han, W.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2017-11-24
- Volume
- 2
- Issue
- 1
- Pages
- 17044-17044
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W2768908212
- Cited by
- 292
- References
- 129
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.